Discussion
There are several reports of haemolytic anaemia and hyperbilirubinaemia in the neonate after administration of methylene blue into the amniotic cavity.
Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue 873
The time of administration has varied from 24 hours to 5 weeks before delivery,2 and in most cases exchange transfusion or phototherapy, or both, was required to control the jaundice. In 2 cases respiratory distress was reported as well3 4 although it is difficult to determine whether or not this was related to the dye. In this case the L/S ratio at the time of amniocentesis was 2-4.
Although methylene blue was not looked for in the baby's urine, the high reticulocyte count of 16% is clear evidence of active haemolysis, and in the absence of blood group incompatibility, infection, or red cell enzyme defect it was felt that methylene blue was strongly implicated as the cause of the haemolysis in this patient. In addition, the amount of methylene blue administered was large (about 70 mg), being greater than the dose used in other reported cases2-4 and far exceeding the dose of 1 -6 mg suggested by Plunkett2 as insufficient to cause haemolysis.
A recent report5 of inadvertent intrauterine injection of methylene blue at 5j weeks' gestation, followed by a normal delivery at term with no ensuing haematological problems, suggests that the dye does not necessarily affect the embryo and that its use for 'diagnosis of premature rupture of membranes should not be condemned'. It may be that the length of time between dye administration and delivery is relevant with respect to the development of haematological problems, but since this length of time cannot be predicted and problems have been reported up to 5 weeks after administration of dye, this procedure may be potentially harmful at any gestation.
Methylene blue is not an innocuous drug and its use for detection of premature rupture of the membranes should be avoided. Received 4 May 1982 Ventricular tap under direct ultrasound control MALCOLM I LEVENE Department ofPaediatrics and Neonatal Medicine, Hammersmith Hospital, London SUMMARY Real-time ultrasound was used for inserting a styletted needle into the lateral ventricle under direct vision. Eight successful taps have been performed using this method in a preterm infant with moderate ventricular dilatation after intraventricular haemorrhage.
The placement of a needle into the lateral cerebral ventricles may be performed as a therapeutic or a diagnostic procedure. Ventriculitis can be diagnosed only by the presence of organisms in the ventricular system, and instillation of antibiotics into the cerebral ventricles may be performed under certain circumstances. In addition, repeated ventricular taps may be undertaken in posthaemorrhagic ventricular dilatation before a shunt can be inserted. In this paper is described a method of inserting a needle into the lateral ventricle under direct ultrasound control.
Methods
An ATL mechanical sector scanner fitted with a 5 MHz transducer was used to visualise the lateral ventricles in coronal section through the temporoparietal bone of a 2-week-old girl born at 29 weeks' gestation with moderately dilated lateral ventricles (ventricular index 13-15 mm)' after intraventricular haemorrhage.
The infant was well wrapped up and placed supine on a mattress lying on a low 
